Development

Articles

Schott and Credence MedSystems have formed a strategic collaboration to make syringe injections safer.

Schott, Credence MedSystems Collaborate to Make Syringe Injections Safer

Eudratec Fasteric is an oral drug delivery technology that offers enteric protection after rapid, homogeneous release for targeting the upper small intestine.

Evonik Launches New Oral Drug Delivery Technology

The companies will work together to produce a wearable device that can subcutaneously deliver ketamine therapy as a non-opioid pain treatment.

Stevanato Group Partners with Bexson Biomedical on a Wearable Drug Delivery Device

Jennifer Markarian is manufacturing editor of BioPharm International.

A device manufacturing process must be carefully designed in the early stages of development to ensure success in commercial manufacturing. 

Manufacturing Drug–Device Combination Products 

Esra’a Albarahmieh is associate professor, Pharmaceutical Chemical Engineering department of the School of Applied Medical Sciences, German Jordanian University.

Mohammad Khanfar is associate professor, Pharmaceutical Chemical Engineering department of the School of Applied Medical Sciences, German Jordanian University.

Emad Alzubi is instructor and workshop manager at the Industrial Engineering department of the School of Applied Technical Sciences, German Jordanian University.

This study suggests that using a simple centrifugal method can produce a natural polymer-blend molecule that can successfully be used as an oral delivery mechanism for poorly soluble drugs. 

Fabrication Modulation of Zein-based Fibers for Oral Delivery of Hydrochlorothiazide

Pharmapack Europe 2021 has been rescheduled after a careful review by the event organizers with key stakeholders.

Pharmapack Organizers Announce 2021 Event to Move from January to May

The new site will offer initial design and development, low-volume manufacturing, and scalable high-quality production of wearable drug delivery devices.

Sorrel to Open a New Manufacturing Facility

Editor of Pharmaceutical Technology Europe

Controlled-release formulations offer numerous advantages for developers and patients, and this market is expected to continue to experience growth in the near future.

Taking a Controlled Approach

Inovio received a $71-million contract from the US Department of Defense to scale up manufacture of its Cellectra smart device to deliver its DNA vaccine.

Inovio to Scale-Up Manufacture of Intradermal Delivery Device for its COVID-19 Vaccine

The investment will give the company the opportunity to accelerate the development of proprietary boron-10 target drugs while it develops its neutron beam accelerator technology for Boron Neutron Capture Therapy.